GSK seeks approval for world's first malaria vaccine
- Written by Editor
- Published in News Feeds
LONDON (Reuters) - GlaxoSmithKline said on Thursday it is applying for regulatory approval for the world's first vaccine against malaria, designed for use in children in Africa.

